Publications by authors named "Robert D Inman"

Claim this Profile
I
Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis.
Patricia Remalante-Rayco, Yassir Daghistani, Tina Chim, Zeynep Baskurt, Sareh Keshavarzi, Robert D Inman

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study.
Denis Poddubnyy, Joachim Sieper, Servet Akar, Santiago Muñoz-Fernández, Hildrun Haibel, Robert D Inman

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).
Denis Choquette, Dafna D Gladman, Robert D Inman, Proton Rahman, Marie-Claude Laliberté

J Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Integrin αvβ6 Autoantibodies as a Biomarker for Ulcerative Colitis in Patients With Axial Spondyloarthritis.
Enoch Yau, Tina Chim, Melissa Lim, Robert D Inman

J Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell immune profiling in ankylosing spondylitis reveals resistance of CD8 T cells to immune exhaustion.
Michael Tang, Zoya Qaiyum, Melissa Lim, Robert D Inman

iScience· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Correspondence on 'Why the term nr-axSpA should not be used for diagnosis'.
Zoya Qaiyum, Robert D Inman

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis.
Patricia Remalante-Rayco, Emmanuel S Baja, Zeynep Baskurt, Tina Chim, Carlo Irwin A Panelo, Robert D Inman

Ann Rheum Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment.
Addison Pacheco, Sinead Maguire, Zoya Qaiyum, Michael Tang, Adam Bridger, Robert D Inman

Arthritis Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of alcohol consumption on clinical outcomes and structural damage in patients with axial spondyloarthritis: A systematic literature review and meta-analysis.
Evelyne Gendron, Sinead Maguire, Melanie Anderson, Sindhu R Johnson, Robert D Inman

Joint Bone Spine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study.
Raphaël Hurtubise, Sherry Rohekar, Nigil Haroon, Zeynep Baskurt, Tina Chim, Robert D Inman

Rheumatol Adv Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).
Proton Rahman, Marco Garrido-Cumbrera, Sherry Rohekar, Michael G Mallinson, Elie Karam, Robert D Inman

Musculoskeletal Care· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study.
Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert Davies Inman, Hideto Kameda

Arthritis Res Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Integrin Blockade on Experimental Spondyloarthritis.
Enoch Yau, Melissa Lim, Zoya Qaiyum, Shaghayegh Foroozan Boroojeni, Michael Tang, Robert D Inman

Biomolecules· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac valve immune profiling in non-radiographic axial spondyloarthritis.
Zoya Qaiyum, Michael Aaron Seidman, Heather Joan Ross, Robert D Inman

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study.
Patricia Remalante-Rayco, Adrian I Espiritu, Yassir Daghistani, Tina Chim, Eshetu Atenafu, Robert D Inman

Rheumatology (Oxford)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
Désirée van der Heijde, Anna Molto, Sofia Ramiro, Jürgen Braun, Maxime Dougados, Robert D Inman

Ann Rheum Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study.
Denis Poddubnyy, Joachim Sieper, Servet Akar, Santiago Muñoz-Fernández, Hildrun Haibel, Robert D Inman

ACR Open Rheumatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis.
Fataneh Tavasolian, Starlee Lively, Chiara Pastrello, Michael Tang, Melissa Lim, Robert D Inman

Ann Rheum Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study.
Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert D Inman, Hideto Kameda

Arthritis Res Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Effects of Integrin Blockade on Gut and Sacroiliac Joint Inflammation.
Zoya Qaiyum, Michael Tang, Pablo Andres Olivera, Robert Davies Inman

J Rheumatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases.
Michelle W Cheung, Roya M Dayam, Janna R Shapiro, Jaclyn C Law, Gary Y C Chao, Robert D Inman

J Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biology and therapeutic potential of mesenchymal stem cell extracellular vesicles in axial spondyloarthritis.
Fataneh Tavasolian, Robert D Inman

Commun Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
Walter P Maksymowych, Robert D Inman, Louis Bessette, Proton Rahman, Emmanouil Rampakakis

Arthritis Res Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis.
Fataneh Tavasolian, Chiara Pastrello, Zuhaib Ahmed, Igor Jurisica, Robert D Inman

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we characterize A-P/IAP behavioural phenotypes in people with chronic pain?
Vaidhehi Veena Sanmugananthan, Joshua C Cheng, Kasey S Hemington, Anton Rogachov, Natalie Rae Osborne, Robert D Inman

Front Pain Res (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis